Allianz Asset Management GmbH Decreases Holdings in Merit Medical Systems, Inc. (MMSI)

Allianz Asset Management GmbH lowered its stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 6.0% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 337,606 shares of the medical instruments supplier’s stock after selling 21,627 shares during the period. Allianz Asset Management GmbH’s holdings in Merit Medical Systems were worth $20,746,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. First Hawaiian Bank acquired a new stake in shares of Merit Medical Systems during the 3rd quarter valued at $107,000. Mutual Advisors LLC acquired a new stake in shares of Merit Medical Systems during the 2nd quarter valued at $208,000. Intrust Bank NA acquired a new stake in shares of Merit Medical Systems during the 2nd quarter valued at $211,000. Alpha Cubed Investments LLC acquired a new stake in shares of Merit Medical Systems during the 3rd quarter valued at $211,000. Finally, Advisors Asset Management Inc. boosted its stake in shares of Merit Medical Systems by 10,444.4% during the 2nd quarter. Advisors Asset Management Inc. now owns 471,864 shares of the medical instruments supplier’s stock valued at $219,000 after buying an additional 467,389 shares during the period. 96.19% of the stock is owned by institutional investors.

MMSI stock opened at $60.59 on Friday. The company has a debt-to-equity ratio of 0.20, a current ratio of 2.77 and a quick ratio of 1.47. Merit Medical Systems, Inc. has a 1 year low of $41.55 and a 1 year high of $66.34. The firm has a market capitalization of $3.37 billion, a P/E ratio of 47.34, a price-to-earnings-growth ratio of 2.83 and a beta of 1.22.

Merit Medical Systems (NASDAQ:MMSI) last released its quarterly earnings data on Thursday, October 25th. The medical instruments supplier reported $0.47 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.42 by $0.05. Merit Medical Systems had a net margin of 4.72% and a return on equity of 10.86%. The business had revenue of $221.66 million during the quarter, compared to analyst estimates of $217.62 million. Equities analysts forecast that Merit Medical Systems, Inc. will post 1.67 earnings per share for the current year.

In related news, EVP Justin J. Lampropoulos sold 20,000 shares of Merit Medical Systems stock in a transaction on Friday, November 16th. The shares were sold at an average price of $61.01, for a total value of $1,220,200.00. Following the completion of the sale, the executive vice president now owns 20,000 shares of the company’s stock, valued at approximately $1,220,200. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director F. Ann Millner sold 9,593 shares of Merit Medical Systems stock in a transaction on Wednesday, October 31st. The shares were sold at an average price of $56.92, for a total transaction of $546,033.56. Following the completion of the sale, the director now directly owns 7,891 shares of the company’s stock, valued at approximately $449,155.72. The disclosure for this sale can be found here. In the last ninety days, insiders sold 41,593 shares of company stock valued at $2,501,846. 5.00% of the stock is owned by company insiders.

A number of equities research analysts have issued reports on the stock. Sidoti set a $79.00 target price on shares of Merit Medical Systems and gave the company a “buy” rating in a research note on Tuesday, October 2nd. Piper Jaffray Companies lifted their target price on shares of Merit Medical Systems from $58.00 to $72.00 and gave the company an “overweight” rating in a research note on Tuesday, October 2nd. Barrington Research lifted their target price on shares of Merit Medical Systems to $69.00 and gave the company an “outperform” rating in a research note on Tuesday, October 2nd. Needham & Company LLC lifted their target price on shares of Merit Medical Systems from $67.00 to $73.00 and gave the company a “buy” rating in a research note on Tuesday, October 2nd. Finally, Zacks Investment Research lowered shares of Merit Medical Systems from a “hold” rating to a “sell” rating in a research note on Wednesday, October 24th. One analyst has rated the stock with a sell rating, nine have assigned a buy rating and two have assigned a strong buy rating to the stock. The stock has an average rating of “Buy” and an average target price of $68.10.

COPYRIGHT VIOLATION WARNING: “Allianz Asset Management GmbH Decreases Holdings in Merit Medical Systems, Inc. (MMSI)” was first reported by WKRB News and is owned by of WKRB News. If you are accessing this story on another site, it was illegally copied and reposted in violation of United States & international copyright and trademark laws. The original version of this story can be accessed at https://www.wkrb13.com/2018/12/07/allianz-asset-management-gmbh-decreases-holdings-in-merit-medical-systems-inc-mmsi.html.

About Merit Medical Systems

Merit Medical Systems, Inc designs, develops, manufactures, and markets various disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through Cardiovascular and Endoscopy segments. It provides various peripheral intervention products, including access, angiography, intervention, and drainage and biopsy products to alleviate patients suffering from peripheral vascular and non-vascular diseases; and cardiac intervention products to aid in the treatment of various cardiac conditions specific to interventional cardiology and electrophysiology, including cardiac rhythm management and lead management.

Further Reading: The Role of a Fiduciary and Individual Investors

Want to see what other hedge funds are holding MMSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merit Medical Systems, Inc. (NASDAQ:MMSI).

Institutional Ownership by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply